An underground economy for unapproved slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.
Investigational Treatment Acquiring Traction Online
The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Followers are urged to message these profiles privately for supplier links, while also obtaining discount codes.
Active Trade on Social Networks
Separately, a robust market exists on Telegram, where groups with thousands of participants share comparison photos, administration instructions and claims of rapid UK delivery. Vendors promote the substance there before redirecting buyers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, physicians and chemists have warned that the distribution of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to individuals administering products of unknown origin.
Several experts stated the demand for retatrutide could be linked to the rising cost of licensed slimming products such as Mounjaro.
Legal Status and Implementation
Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for personal consumption under the British medical regulations.
Several content creators try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and distribution can still violate medicines, marketing, and customer laws, risking penalties, legal action or imprisonment.
Service Response and Content Elimination
According to the social media company, the platform has removed problematic content and banned associated keywords and query recommendations. The company said it was committed to keeping the platform safe and allocating resources in enhancing compliance measures.
Online Trading Activities
Research also discovered communities with up to nine thousand members selling the experimental drug using Telegram's integrated search feature, which functions like a public directory. Entering “retatrutide” instantly brings up groups with numerous of members, filled with images of weight loss, glowing testimonials and detailed guides for preparing or administering at home.
After minutes of entering one group, a vendor shared WhatsApp details, where most transactions take place. The seller provided an guidebook and guaranteed shipping within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about weight, medical conditions or previous experience.
Item Details and Costs
Inside these communities, posts show dark colored packages with postal service labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use injectors usually priced at £160 for 20mg. When questioned how much time a injector should be used, vendors give conflicting answers varying between a few weeks to “depends on your body”.
Service Moderation and Safety Actions
A spokesperson for the messaging service said it regularly moderated harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting materials they can’t verify. Even if the research behind this drug is sound, these digital versions may not include what they claim,” said Jason Murphy, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of an online medical service connected the increase in demand to current price rises for authorized slimming medications such as Mounjaro. “With costs increasing, individuals are using online platforms. But fake treatments are extremely dangerous. You can’t be certain what’s inside or whether the conditions they were made in was clean,” she said.
Her staff has already encountered patients harmed by personal administration from unconfirmed sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said the doctor. “These substances could be impure or incorrectly dosed.”
Producer Statement
A representative from Eli Lilly said the substance was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company experimental product not yet approved … may subject users to possibly significant medical dangers”.
